Être à jour (fr)

Données cartographiées des épidémies

Lisez les dernières nouvelles officielles de l'OMS et du CDC, répertoriées ci-dessous dans la section Flux d'actualités, en commençant par les plus récentes. Voyez les avis des deux organisations cartographiés au niveau mondial immédiatement ci-dessous.**

Skip maps

**Actualisez si la carte ne se charge pas immédiatement. Sachez que toutes les informations n'apparaissent pas sur la carte. Voir également les fils d'actualités ci-dessous.  

Fil d'actualité

Skip Fil d'actualité

Flambées épidémiques de l'OMS

  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 13 Jun 2019
    The Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) continues to show a decrease in the number of new cases in hotspots such as Katwa, Beni and Kalunguta health zones. However, in other areas such as Mabalako and Butembo, moderate rates of transmission continue. With ongoing EVD transmission within communities in 12 health zones in North Kivu and Ituri provinces, factors such as persistent delays in case detection, approximately a third of cases dying outside of Ebola treatment or transit centres, and high population mobility, pose a high risk of geographical spread both within the DRC and to neighbouring countries. This was highlighted by the recent exportation of cases to Uganda – the first confirmed cases detected outside of North Kivu and Ituri province since the onset of the outbreak over 10 months ago. For more information, please see Disease Outbreak News on EVD in Uganda

    Weekly decrease in the incidence of new cases have been reported in several health zones; however, increase or a continuation of the outbreak has been observed in others (Figure 1). In the 21 days, between 22 May to 11 June 2019, 62 health areas within 12 health zones reported new cases, representing 9% of the 664 health areas within North Kivu and Ituri provinces (Figure 2). During this period, a total of 212 confirmed cases were reported, the majority of which were from the health zones of Mabalako (33%, n=69), Butembo (18%, n=39), Katwa (14%, n=30) Mandima (11%, n=23) and Beni (9%, n=20). Single confirmed cases were also reported from Rwampara and Komanda health zones this past week following a prolonged period since the last reported case, with both cases acquiring the infection in the aforementioned hotspots.
  • Ebola virus disease – Republic of Uganda...
    Thu, 13 Jun 2019
    On 11 June 2019, the Ugandan Ministry of Health (MoH) has confirmed a case of Ebola Virus Disease (EVD) in Kasese district, Uganda. The patient is a 5-year-old child from the Democratic Republic of Congo (DRC) who travelled with his family from Mabalako Health Zone in DRC after attending, on 1 June 2019, the funeral of his grandfather (confirmed EVD case on 2 June 2019). On 10 June 2019, the child and the family entered the country through Bwera border post and sought medical care at Kagando hospital where health workers identified Ebola as a possible cause of illness. The child was transferred to Bwera Ebola Treatment Unit (ETU) for management. The confirmation of Ebola Virus was made on 11 June 2019 at the Uganda Virus Research Institute (UVRI), and the child has deceased in the early hours of 12 June 2019. Two other suspected cases, a 50-year-old female (grandmother of the first case) and 3-year-old male (younger brother of the first case) part of the family members who travelled together with the first confirmed child were also admitted in the same ETU and were confirmed for EVD by UVRI on 12 June 2019. The 50 year-old-female died during the night between 12 and 13 June. 27 other contacts have been identified and are being monitored. Healthcare workers from both health care facilities where the child was treated have been previously vaccinated.

    All three confirmed cases are imported from DRC and belong to the same family who travelled together from Mabalako Health Zone, an area currently affected by Ebola outbreak in North Kivu, DRC. To date, they remain as a single episode of EVD in Uganda, and the geographical spread in Uganda appears to be limited to one district near DRC border. Further investigations are ongoing both in Uganda and DRC to assess the full extent of the outbreak.
  • Circulating vaccine-derived poliovirus type 2 – Cameroon...
    Thu, 06 Jun 2019
    On 23 May 2019, WHO received notification through the Global Polio Laboratory Network (GPLN) of the detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) from an environmental sample collected on 20 April 2019 in a hospital in Northern Cameroon which borders Borno state in Nigeria and Chad.

Notices de voyage du CDC:


Cliquez ici pour rechercher des maladies liées aux voyages par nation.

L'assistant clinique de voyage (Travel Clinical Assistant - TCA) est du Département de la santé de la Géorgie.


Rapport hebdomadaire de la morbidité et de la mortalité (MMWR) du CDC:


Mises à jour actuelles du journal

Skip Mises à jour actuelles du journal

Clinical Infectious Diseases Journal

This list includes items from the latest issue of the Clinical Infectious Diseases Journal.

Écoute: New England Journal of Medicine

The New England Journal of Medicine is a weekly general medicine journal, and this audio news feed presents interviews with specialists.

  • NEJM Interview: Dr. Deborah Dowell on concerns about misimplement...
    Wed, 12 Jun 2019
    Dr. Deborah Dowell is the chief medical officer of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D. Dowell, T. Haegerich, and R. Chou. No Shortcuts to Safer Opioid Prescribing. N Engl J Med 2019;380:2285-2287.
  • NEJM Interview: Dr. Michael F. Clarke on clinical and therapeutic...
    Wed, 05 Jun 2019
    Dr. Michael F. Clarke is a professor at Stanford Medical School and Associate Director of the Institute for Stem Cell Biology and Regenerative Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M.F. Clarke. Clinical and Therapeutic Implications of Cancer Stem Cells. N Engl J Med 2019;380:2237-2245.
  • NEJM Interview: Dr. Anthony Fauci on troubling increases in measl...
    Wed, 05 Jun 2019
    Dr. Anthony Fauci is director of the National Institute of Allergy and Infectious Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C.I. Paules, H.D. Marston, and A.S. Fauci. Measles in 2019 — Going Backward. N Engl J Med 2019;380:2185-2187. R.D. Silverman, D.J. Opel, and S.B. Omer. Vaccination over Parental Objection — Should Adolescents Be Allowed to Consent to Receiving Vaccines? N Engl J Med. DOI: 10.1056/NEJMp1905814. J.D. Cantor. Mandatory Measles Vaccination in New York City — Reflections on a Bold Experiment. N Engl J Med. DOI: 10.1056/NEJMp1905941.

Emerging Infectious Diseases Journal:

This list contains articles published online ahead of print.


Center for Infectious Disease Research and Policy:

News from the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP).

Johns Hopkins Medicine RSS Feed:

Johns Hopkins Medicine science and medical news.

  • Study Shows Increased Risk of Uterine Fibroids in African-America...
    Thu, 28 Dec 2017
    In a study of medical records gathered on hundreds of thousands of African-American women, Johns Hopkins researchers say they have evidence that women with a common form of hair loss have an increased chance of developing uterine leiomyomas, or fibroids.
  • More Tumor Mutations Equals Higher Success Rate With Cancer Immun...
    Wed, 20 Dec 2017

    The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows. The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs.

  • How Electroconvulsive Therapy Relieves Depression Per Animal Expe...
    Mon, 18 Dec 2017
    In a study using genetically engineered mice, Johns Hopkins researchers have uncovered some new molecular details that appear to explain how electroconvulsive therapy (ECT) rapidly relieves severe depression in mammals, presumably including people. The molecular changes allow more communication between neurons in a specific part of the brain also known to respond to antidepressant drugs.

American Journal of Infection Control:

RSS feed including 'the latest published articles, both published in an issue and published as Articles in Press.'

  • Prevalence of mupirocin and chlorhexidine resistance among methi...
    The widespread of methicillin-resistant Staphylococcus aureus (MRSA) antimicrobial decolonization in the clinical setting may lead to an increase in the prevalence of multiresistance to coagulase-negative staphylococci (CoNS) owing to their selection. This study aimed to investigate the impact of MRSA decolonization strategies, using mupirocin and chlorhexidine, on their CoNS susceptibility.
  • Evaluating differences in tuberculosis and nontuberculous mycoba...
    When a patient presents with acid-fast bacilli (AFB) in a respiratory specimen, infection preventionists and public health professionals are often faced with a challenging decision.1
  • Clostridium difficile intervention timelines for diagnosis, isol...
    Clostridium difficile infection (CDI) has become the leading cause of nosocomial diarrhea worldwide.1-3 The costs of CDI management and health care resource utilization inflict a substantial economic burden, largely due to prolonged hospital stays, patient isolation, and recurrence.4-7 Despite the availability of treatment options that are effective in most primary cases, CDI relapse or recurrence can occur, thereby increasing rates of transmission to other in-hospital patients by various means, including contaminated surfaces.